Your browser doesn't support javascript.
loading
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
Hecht, Markus; Meier, Friedegund; Zimmer, Lisa; Polat, Bülent; Loquai, Carmen; Weishaupt, Carsten; Forschner, Andrea; Gutzmer, Ralf; Utikal, Jochen S; Goldinger, Simone M; Geier, Michael; Hassel, Jessica C; Balermpas, Panagiotis; Kiecker, Felix; Rauschenberg, Ricarda; Dietrich, Ursula; Clemens, Patrick; Berking, Carola; Grabenbauer, Gerhard; Schadendorf, Dirk; Grabbe, Stephan; Schuler, Gerold; Fietkau, Rainer; Distel, Luitpold V; Heinzerling, Lucie.
Affiliation
  • Hecht M; Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Meier F; Department of Dermatology, University Hospital Dresden, Dresden, Germany.
  • Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Polat B; Department of Radiation Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • Weishaupt C; Department of Dermatology, University Hospital Münster, Münster, Germany.
  • Forschner A; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Gutzmer R; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Utikal JS; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Goldinger SM; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Geier M; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
  • Hassel JC; Department of Radiation Oncology, Ordensklinikum Linz, Linz, Austria.
  • Balermpas P; Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Kiecker F; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Rauschenberg R; Department of Dermatology, University Hospital Berlin, Berlin, Germany.
  • Dietrich U; Department of Dermatology, University Hospital Dresden, Dresden, Germany.
  • Clemens P; Department of Dermatology, University Hospital Dresden, Dresden, Germany.
  • Berking C; Department of Radiation Oncology, Hospital Feldkirch, Feldkirch, Austria.
  • Grabenbauer G; Department of Dermatology, University Hospital LMU Munich, München, Germany.
  • Schadendorf D; Department of Radiation Oncology, Hospital Coburg, Coburg, Germany.
  • Grabbe S; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Schuler G; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • Fietkau R; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
  • Distel LV; Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Heinzerling L; Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.
Br J Cancer ; 118(6): 785-792, 2018 03 20.
Article de En | MEDLINE | ID: mdl-29438368
ABSTRACT
This corrects the article DOI 10.1038/bjc.2017.85.
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Protocoles de polychimiothérapie antinéoplasique / Protéines proto-oncogènes B-raf / Mélanome Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Cancer Année: 2018 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Protocoles de polychimiothérapie antinéoplasique / Protéines proto-oncogènes B-raf / Mélanome Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Cancer Année: 2018 Type de document: Article Pays d'affiliation: Allemagne